An official website of the United States government

This repository is under review for potential modification in compliance with Administration directives.
NIH: National Institute of Diabetes and Digestive and Kidney Diseases
NIDDK Central Repository
Search
Filters

Study Acronym

AASK Trial

1 - 45 of 45 Results
  • 1
Page
Show:
Study Search Results Table
Title
PMID
PMCID
Public Release Type
Publication Year
DOI
Study Acronym
Study Network
Request ID(s)
Public Release Origin
A New Panel Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population33301877PMC8102017Journal202110.1053/j.ajkd.2020.11.005AASK Trial20522Secondary Research
APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial28758155PMC5527675Journal201710.1016/j.ekir.2017.03.008AASK Trial20241, 20271, 20272Secondary Research
APOL1 Risk Variants and Subclinical Cardiovascular Disease in Incident Hemodialysis Patients33615058PMC7879092Journal202010.1016/j.ekir.2020.11.006AASK Trial21579Secondary Research
APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes25054777PMC4281283Journal201410.1038/ki.2014.255AASK Trial20241, 20271, 20272Secondary Research
Acute declines in eGFR in blood pressure target trials and risk of adverse outcomesJournal2023AASK Trial, MDRD, AASK Cohort4528Secondary Research
Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium30630856PMC6481269Journal201910.1136/bmj.k5301AASK Trial20733Secondary Research
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis34461040PMC8473559Journal202110.1016/S0140-6736(21)01921-8AASK Trial22859Secondary Research
Antihypertensive drug effects on long-term blood pressure: an individual-level data metaanalysis of randomised clinical trials35058294PMC9340038Journal202210.1136/heartjnl-2021-320171AASK Trial22859Secondary Research
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials35058294PMC9340038Journal202210.1136/heartjnl-2021-320171AASK Trial22859Secondary Research
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis33794209PMC8024901Journal202110.1016/S1470-2045(21)00033-4AASK Trial22859Secondary Research
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis33794209PMC8024901Journal202110.1016/S1470-2045(21)00033-4AASK Trial22859Secondary Research
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial25029429PMC4281289Journal201410.1038/ki.2014.254AASK Trial20241, 20271, 20272Secondary Research
Associations of Baseline and Longitudinal Uromodulin with ESKD and Mortality: Results from AASKJournal2023AASK Trial21579Secondary Research
Circulating Branched-Chain Amino Acids, Incident Cardiovascular Disease, and Mortality in the African American Study of Kidney Disease and Hypertension.36716198PMC9974782Journal202310.1161/CIRCGEN.122.003729AASK Trial20733Secondary Research
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial28985268PMC5861531Journal201710.1093/ajh/hpx138AASK Trial20271Secondary Research
Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury37292692Journal202310.1101/2023.05.16.23290051AASK Trial, ASSESS-AKI23204Secondary Research
Comparison of Aptamer-based and Antibody-based Assays for Protein Quantification in Chronic Kidney Disease35197258Journal202210.2215/CJN.11700921AASK Trial21579Secondary Research
Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review33853887PMC8425659Journal202110.1681/ASN.2020101399AASK Trial20271Secondary Research
Dietary acid load: A novel nutritional target in chronic kidney disease?23439373PMC3604792Journal201310.1053/j.ackd.2012.11.001AASK Trial20048Secondary Research
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.26362696PMC4695294Journal201610.1053/j.ajkd.2015.07.025AASK Trial20522Secondary Research
Gene Set Enrichment Analyses Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy34166655PMC8678352Journal202110.1016/j.ajo.2021.06.014AASK Trial20271Secondary Research
Genome-wide association study of serum metabolites in the African American Study of Kidney Disease and Hypertension.33838163PMC8583323Journal202110.1016/j.kint.2021.03.026AASK Trial20733Secondary Research
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared to Standard Blood Pressure Control29021322PMC5760457Journal201710.1161/CIRCULATIONAHA.117.030848AASK Trial20271Secondary Research
Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney Disease and Hypertension.36329547PMC9635174Journal202210.1186/s40246-022-00425-9AASK Trial20733Secondary Research
Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion33534524PMC8994118Journal202210.1097/TP.0000000000003641AASK Trial20271Secondary Research
Intensive blood pressure control in patients with chronic kidney disease and risk for adverse outcomesJournal2023MDRD, AASK Trial, AASK Cohort4528Secondary Research
Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D35314457Journal202210.1681/ASN.2021060735AASK Trial21579Secondary Research
Metabolite Biomarkers of CKD Progression in Children34362785PMC8455058Journal202110.2215/CJN.00220121AASK Trial20733Secondary Research
Multiethnic Genome-wide Association Study of Subclinical Atherosclerosis in Individuals with Type 2 Diabetes34241534PMC8435075Journal202110.1161/CIRCGEN.120.003258AASK Trial20271Secondary Research
Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in American cohorts38101514Journal202310.1016/j.kint.2023.11.024MDRD, AASK Trial, DCCT/EDIC, PERL, CRISP, AASK Cohort, ALTOLD, CRIC23649Secondary Research
Proteomics: Progress and Promise of High-Throughput Proteomics in Chronic Kidney Disease37076045PMC10326701Journal202310.1016/j.mcpro.2023.100550AASK Trial20733Secondary Research
Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study32894582PMC7855571Journal202110.1111/jgs.16797AASK Trial20733, 21008, 21579Secondary Research
Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task Force33845065PMC8238889Journal202110.1053/j.ajkd.2021.03.008AASK Trial20522Secondary Research
Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force33837122PMC8259639Journal202110.1681/ASN.2021010039AASK Trial20522Secondary Research
Reducing Kidney Function Decline in Patients With CKD: Core Curriculum 202133892998PMC8227808Journal202110.1053/j.ajkd.2020.12.022AASK Trial20733, 21008, 21579Secondary Research
Research Needs to Improve Hypertension Treatment and Control in African Americans27620388PMC5063700Journal201610.1161/HYPERTENSIONAHA.116.07905AASK Trial20271Secondary Research
Risk of ESRD and Mortality Associated With Change in Filtration Markers.28648303PMC5610931Journal201710.1053/j.ajkd.2017.04.025AASK Trial20522Secondary Research
Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study26948990PMC4921300Journal201610.1053/j.ajkd.2016.01.015AASK Trial20522Secondary Research
Standardization of serum creatinine is essential for accurate use of unbiased estimating GFR equations. Evidence from three cohorts matched on renal function.36381377Journal202210.1093/ckj/sfac182AASK Trial, CRIC, AASK Cohort23401Secondary Research
The Serum Metabolome Identifies Biomarkers of Dietary Acid Load in 2 Studies of Adults with Chronic Kidney Disease.30919901PMC6461721Journal201910.1093/jn/nxy311AASK Trial20522, 20733Secondary Research
The retention of rhythmic components in blood pressure: a novel prognostic indicator in chronic kidney diseaseConference Presentation2022AASK Trial, AASK Cohort22857Secondary Research
Transcriptome- and proteome-wide association studies nominate determinants of kidney function and damage37365616PMC10291807Journal202310.1186/s13059-023-02993-yAASK Trial20733Secondary Research
Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases35372821PMC8967726Journal202210.1016/j.xkme.2022.100442AASK Trial20522, 20733Secondary Research
Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease32572055PMC7308283Journal202010.1038/s41598-020-66334-wAASK Trial20733Secondary Research
Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study27825313PMC5101703Journal201610.1186/s12882-016-0383-7AASK Trial20733Secondary Research
  • 1
Page